e-learning
resources
London 2016
Sunday, 04.09.2016
Community-acquired pneumonia: from prevention to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Leyre Serrano Fernandez, Rafael Zalacain, Alberto Capelastegi, Ainhoa Gomez, Lorea Martinez-Indart, Marta Garcia, Ane Uranga, Pedro Pablo España, Luis Alberto Ruiz
Source:
International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Session:
Community-acquired pneumonia: from prevention to treatment
Session type:
Poster Discussion
Number:
606
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Leyre Serrano Fernandez, Rafael Zalacain, Alberto Capelastegi, Ainhoa Gomez, Lorea Martinez-Indart, Marta Garcia, Ane Uranga, Pedro Pablo España, Luis Alberto Ruiz. Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen. Eur Respir J 2016; 48: Suppl. 60, 606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Community-acquired pneumonia due to
streptococcus pneumoniae
in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Prognostic factors of bacteremic pneumococcal pneumonia (BPP)
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1214
Year: 2014
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1213
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept